ProfileGDS5678 / 1435231_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 52% 53% 53% 53% 57% 51% 44% 53% 59% 53% 53% 53% 55% 52% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.3086252
GSM967853U87-EV human glioblastoma xenograft - Control 23.3051453
GSM967854U87-EV human glioblastoma xenograft - Control 33.3086153
GSM967855U87-EV human glioblastoma xenograft - Control 43.254753
GSM967856U87-EV human glioblastoma xenograft - Control 53.3968257
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.3328951
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.0967644
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.2809653
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.5246759
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.2925853
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.2769353
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.2524453
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.4021355
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.2751852